Suppr超能文献

左旋舒必利所致肌张力障碍:7例

Levosulpiride-Induced Dystonia: 7 Cases.

作者信息

Radhakrishnan Divya M, Goyal Vinay

机构信息

Senior Research Officer,Department of Neurology, All India Institute of Medical Sciences, New Delhi.

Professor, Department of Neurology, All India Institute of Medical Sciences, New Delhi.

出版信息

J Assoc Physicians India. 2018 Jun;66(6):95-96.

Abstract

Levosulpiride is a newer prokinetic agent with increasingly extensive use in India by general physicians. Levosulpiride selectively inhibits gut and central D2 receptors and is associated with various movement disorders like- tremor, Parkinsonism, dyskinesias and rarely dystonia. We report 7 cases of levosulpirideinduced dystonia at our institute. Though all patient had at least 50% improvement after discontinuation of levosulpiride, none had complete recovery at mean follow up of 5.5 months. Through this article we want to highlight extrapyramidal side effects of levosulpiride, need of its awareness among physicians.

摘要

左舒必利是一种新型促动力药物,在印度被普通医生越来越广泛地使用。左舒必利选择性抑制肠道和中枢D2受体,并与各种运动障碍有关,如震颤、帕金森综合征、运动障碍,很少引起肌张力障碍。我们在我院报告了7例左舒必利引起的肌张力障碍病例。虽然所有患者在停用左舒必利后至少有50%的改善,但在平均5.5个月的随访中,没有一例完全康复。通过本文,我们想强调左舒必利的锥体外系副作用,以及医生对其认识的必要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验